2015
DOI: 10.3823/1813
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular risk in HIV/AIDS and Lipodystrophy Syndrome patients

Abstract: Background: The treatment of people living with AIDS, known a highly active antiretroviral therapy (HAART), has increased considerably, and the disease has therefore acquired chronic features. Several changes have been observed, especially in cardiovascular disease risk. Methods: This is a descriptive cross-sectional study. 192 patients were recruited from a lipodystrophy outpatient centre, using Framingham risk scores.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 28 publications
(34 reference statements)
0
1
0
Order By: Relevance
“…The knowledge gap regarding vaccine indications in HIV-positive individuals arises from misinformation about the safety of the HPV vaccine in immunosuppressed patients. The vaccine is safe in patients living with HIV and may be given after a medical prescription because it contains no live or attenuated virus but instead contains proteins without viral particles 7,25-27.…”
Section: Discussionmentioning
confidence: 99%
“…The knowledge gap regarding vaccine indications in HIV-positive individuals arises from misinformation about the safety of the HPV vaccine in immunosuppressed patients. The vaccine is safe in patients living with HIV and may be given after a medical prescription because it contains no live or attenuated virus but instead contains proteins without viral particles 7,25-27.…”
Section: Discussionmentioning
confidence: 99%